# A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

> **NCT03572387** · PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 14 (actual)

## Conditions studied

- Prostatic Neoplasms
- Prostate Neoplasms
- Prostate Cancer

## Interventions

- **DRUG:** 5-Azacitidine
- **DRUG:** all trans retinoic acid
- **DRUG:** Lupron

## Key facts

- **NCT ID:** NCT03572387
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2022-06-19
- **Final completion:** 2022-07-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03572387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03572387, "A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT03572387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*